Smith & Nephew PLC (SNN)
25.31
+0.27
(+1.08%)
USD |
NYSE |
Nov 22, 16:00
25.32
+0.01
(+0.04%)
Pre-Market: 20:00
Smith & Nephew Price: 25.31 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 22, 2024 | 25.24 | 25.36 | 25.08 | 25.31 | 769118.0 |
Nov 21, 2024 | 25.14 | 25.17 | 24.93 | 25.04 | 664873.0 |
Nov 20, 2024 | 25.18 | 25.24 | 25.02 | 25.21 | 644992.0 |
Nov 19, 2024 | 25.40 | 25.57 | 25.22 | 25.51 | 1.234M |
Nov 18, 2024 | 24.89 | 25.56 | 24.88 | 25.54 | 2.067M |
Nov 15, 2024 | 24.66 | 24.93 | 24.64 | 24.89 | 1.019M |
Nov 14, 2024 | 24.73 | 24.92 | 24.63 | 24.64 | 952476.0 |
Nov 13, 2024 | 24.58 | 24.72 | 24.49 | 24.62 | 1.050M |
Nov 12, 2024 | 24.92 | 25.09 | 24.56 | 24.58 | 1.363M |
Nov 11, 2024 | 24.68 | 24.75 | 24.44 | 24.74 | 1.273M |
Nov 08, 2024 | 24.26 | 24.40 | 24.01 | 24.29 | 1.156M |
Nov 07, 2024 | 24.64 | 24.77 | 24.46 | 24.70 | 888435.0 |
Nov 06, 2024 | 24.12 | 24.51 | 23.85 | 24.48 | 1.118M |
Nov 05, 2024 | 25.80 | 25.80 | 25.48 | 25.56 | 463392.0 |
Nov 04, 2024 | 25.10 | 25.40 | 25.09 | 25.28 | 692459.0 |
Nov 01, 2024 | 25.65 | 25.84 | 25.14 | 25.24 | 1.070M |
Oct 31, 2024 | 25.46 | 25.62 | 24.82 | 25.09 | 2.505M |
Oct 30, 2024 | 28.59 | 29.06 | 28.57 | 28.85 | 1.709M |
Oct 29, 2024 | 28.63 | 28.98 | 28.54 | 28.87 | 824017.0 |
Oct 28, 2024 | 28.82 | 28.96 | 28.74 | 28.85 | 341316.0 |
Oct 25, 2024 | 28.27 | 28.48 | 28.13 | 28.37 | 1.139M |
Oct 24, 2024 | 29.39 | 29.60 | 29.25 | 29.50 | 839189.0 |
Oct 23, 2024 | 29.14 | 29.28 | 29.12 | 29.23 | 313383.0 |
Oct 22, 2024 | 29.39 | 29.47 | 29.31 | 29.44 | 230911.0 |
Oct 21, 2024 | 29.53 | 29.59 | 29.33 | 29.37 | 309369.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
21.55
Minimum
Oct 26 2023
51.64
Maximum
Feb 20 2020
33.26
Average
31.76
Median
Price Benchmarks
Biodexa Pharmaceuticals PLC | 4.57 |
Bicycle Therapeutics PLC | 20.54 |
Haleon PLC | 9.65 |
Adaptimmune Therapeutics PLC | 0.6616 |
Verona Pharma PLC | 38.81 |
Price Related Metrics
PE Ratio | 36.26 |
PS Ratio | 1.959 |
Price to Book Value | 2.12 |
Earnings Yield | 2.76% |
Market Cap | 11.03B |
Operating PE Ratio | 15.50 |
Normalized PE Ratio | 36.26 |